Voriconazole
Back to searchMolecule Structure
Scientific Name
Voriconazole
Description of the Drug
Voriconazole is a triazole compound used to treat fungal infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00582
http://www.drugbank.ca/drugs/DB00582
Brand Name(s)
Vfend, Voriconazole
Company Owner(s)
Xellia Pharmaceuticals Aps, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Akorn Operating Co Llc, Rising Pharma Holdings Inc, Ajanta Pharma Ltd, Aurobindo Pharma Ltd, Amneal Pharmaceuticals, Sandoz Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 51 | SINGLE PROTEIN | INHIBITOR | CHEMBL1780 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL36233 | |
PharmGKB | PA10233 | |
Human Metabolome Database | HMDB0014720 | |
DrugBank | DB00582 | |
PubChem: Thomson Pharma | 14900759 | 14754154 |
PubChem | 71616 | |
LINCS | LSM-5244 | |
Nikkaji | J709.476K | |
PDBe | VOR | |
BindingDB | 50333117 | |
EPA CompTox Dashboard | DTXSID5046485 | |
DrugCentral | 2846 | |
Rhea | 10023 | |
ChemicalBook | CB01123117 | CB1160110 |
rxnorm | VORICONAZOLE | VFEND |
PubChem: Drugs of the Future | 12014673 | |
KEGG Ligand | C07622 | |
ChEBI | 10023 | |
ZINC | ZINC000000014864 |